ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993